{"id":22001,"date":"2012-04-11T17:21:04","date_gmt":"2012-04-11T21:21:04","guid":{"rendered":"http:\/\/1boringoldman.com\/?p=22001"},"modified":"2012-04-12T18:28:40","modified_gmt":"2012-04-12T22:28:40","slug":"22001","status":"publish","type":"post","link":"https:\/\/1boringoldman.com\/index.php\/2012\/04\/11\/22001\/","title":{"rendered":"can&#8217;t imagine&#8230;"},"content":{"rendered":"<br \/>\n<blockquote>\n<div align=\"center\"><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8890670\" target=\"_blank\"><u><strong><font color=\"#200020\">Redefining the role of psychiatry in medicine.<\/font><\/strong><\/u><\/a><br \/>              <sup>by Lieberman JA and Rush AJ<\/sup><br \/>              <strong><font color=\"#004400\">American Journal of Psychiatry<\/font><\/strong>. <strong><font color=\"#990000\">1996<\/font><\/strong> 153:1388-1397.<\/div>\n<p>            <\/p>\n<div align=\"justify\"><sup>&#8230; The delivery of psychiatric services would be reorganized to  emphasize what psychiatrists can do best. For example, the initial  diagnostic evaluation would involve a reordering of services, with  psychiatrists being the first to consult [after primary care physicians]  regarding patients with complaints or disturbances in behavior, affect,  perception, and cognition. If a diagnostic evaluation revealed a common  problem in living [e.g., marital problem, minor sexual dysfunction] for  which only psychotherapy was called for, the patient would be referred  to a nonmedical mental health practitioner for treatment, but after  treatment the patient would be reevaluated by the psychiatrist to  determine whether the treatment outcome was as expected. If the outcome  was not satisfactory, revisions in the treatment plan would be made  through consultation between the psychiatrist and therapist. This  arrangement would help to ensure the appropriate use of time-intensive  treatments by psychiatrists, who would have no economic investment in  their extended use. <\/p>\n<p>              In addition to having a pivotal diagnostic  role, psychiatrists would treat with medication, psychotherapy [often by  way of a therapist responsible to the psychiatrist], or the combination  of these for patients with complex, &quot;treatment-resistant,&quot; or  chronic\/recurrent disorders. Psychiatrists would have a greater role in  the diagnosis and treatment of the psychiatric sequelae of general  medical conditions [e.g., diabetes, cancer] and neurologic disorders [e.g., stroke], since they would be better prepared than primary care  physicians to separate normal psychological responses [which require the  passage of time with support and reassurance] from true psychiatric  disorders that require formal treatment. What are now diverse bodies of  knowledge found in neurology and psychiatry would be brought together to  serve patients more efficiently. The extensive interpersonal and  communication skills acquired by psychiatrists in their training would  enable them to enliven even the most routine clinical functions, such as  medication management. <\/p>\n<p>              The general notion is of a &quot;one-stop&quot;  specialist for disorders that affect behavior, cognition, perception,  and affect, whether from known or unknown etiologies. Emphasis on  psychotherapy would not be eliminated but, rather, would be reduced in  priority. The focus would be on the indications for and expected  outcomes of different psychotherapeutic treatments to be delivered  largely by nonphysicians. A limited number of psychiatrists might wish  to specialize in psychosocial rehabilitation, which would be analogous  to neuropsychiatric rehabilitation medicine&#8230;<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\">This wasn&#8217;t that long ago &#8211; sixteen years. It was in some ways a capitulation, or maybe some kind of acceptance of the state of affairs at the time &#8211; the rise of Managed Care and the turning over of psychological treatment [psychotherapy] to other disciplines &#8211; perhaps not so much by design but rather adapting to the lay of the land. But there are some things in the assumptions made by Dr. Lieberman and Dr. Rush that, in retrospect, look naive. In their model, they place the psychiatrist at the top of a mental health heirarchy:<\/div>\n<ul><sup>  <\/p>\n<div align=\"justify\">&bull; &quot;with  psychiatrists being the first to consult&quot;<\/div>\n<div align=\"justify\">&bull; &quot;If a diagnostic evaluation revealed a common  problem in living [e.g.,  marital problem, minor sexual dysfunction] for  which only psychotherapy  was called for, the patient would be referred  to a nonmedical mental  health practitioner for treatment, but after  treatment the patient  would be reevaluated by the psychiatrist to  determine whether the  treatment outcome was as expected&quot;<\/div>\n<div align=\"justify\">&bull; &quot;psychiatrists would treat with medication, psychotherapy [often by  way  of a therapist responsible to the psychiatrist], or the combination  of  these for patients with complex, &quot;treatment-resistant,&quot; or   chronic\/recurrent disorders&quot;<\/div>\n<div align=\"justify\">&bull; &quot;a greater role in  the diagnosis and treatment of the psychiatric sequelae of general  medical conditions&quot;<\/div>\n<div align=\"justify\">&bull; &quot;since they would be better prepared than primary care  physicians to  separate normal psychological responses [which require the  passage of  time with support and reassurance] from true psychiatric  disorders that  require formal treatment&quot;<\/div>\n<div align=\"justify\">&bull; &quot;The extensive interpersonal and  communication skills acquired by  psychiatrists in their training would  enable them to enliven even the  most routine clinical functions, such as  medication management&quot;<\/div>\n<p> <\/sup><\/ul>\n<p align=\"justify\">I suppose their assumption that the psychiatrist would direct the show &#8211; a diagnostician first and foremost, making a diagnosis, delivering the medical-psychiatric care, farming out the psychotherapy, and certifying the result &#8211; made sense in light of how things had always been. Then there&#8217;s moving onto the medical floors for a greater role in the care of the physically sick [the enlivened <em>med checks<\/em> were perhaps a bit of fluff]. It&#8217;s not an unfamiliar model. It&#8217;s the model of Internal Medicine or  other specialties. Once the evaluation is done, the  diagnosis and plan put together, the delivery is often farmed out. It&#8217;s a  mutually beneficial arrangement. The people delivering the care  appreciate the up front expertise and the back-up. The specialist has  time to &quot;specialize.&quot; It&#8217;s something of a consulting relationship.  Nowdays, the hospitalist or primary care physician is central, and  multiple consultants come and go as needed.<\/p>\n<div align=\"justify\">Well it didn&#8217;t exactly work out as they planned. None of it. They made the assumption that psychiatrists would be in the driver&#8217;s seat as they always had been in mental health. The DSM-IV was in its infancy and had become the industry standard. What they didn&#8217;t take into account was that the position they envisioned for psychiatrists was hardly a given &#8211; it was to be earned through demonstrated expertise and by mutual respect. Psychiatry, as a specialty failed dramatically in both dimensions. Prophetically, in 1996, Author John Rush was in Texas starting up TMAP, a pharmaceutical scam for all seasons and planning STAR*D, a $35 M research failure. He&#8217;s currently on the lam in Singapore. Dr. Lieberman fared better, moving that year to UNC, shepherding the CATIE Trial, and becoming Chairman at Columbia in 2005. He&#8217;s slated to become President of the APA in May 2013 at the time when the DSM-5 will be released to what looks like may be an international boycott, and this week he moderated a relatively bizarre APA\/APF Conference:     <\/div>\n<blockquote>\n<div align=\"center\"><a target=\"_blank\" href=\"http:\/\/psychnews.psychiatryonline.org\/newsArticle.aspx?articleid=1096598\"><u><strong><font color=\"#200020\">APF Convenes Unique Pipeline Summit<\/font><\/strong><\/u><\/a><br \/>        <strong><font color=\"#200020\">Psychiatric News<\/font><\/strong><br \/>        by Jun Yan<br \/>        April 06, <strong><font color=\"#990000\">2012<\/font><\/strong><\/div>\n<p>       <\/p>\n<div align=\"justify\"><sup>With  the pharmaceutical industry weary of investing in psychiatric drug  development, collaboration across public and private sectors seems to be  the only way to remedy a dearth of new treatments. Leaders from academia, government, the  pharmaceutical industry, venture-capital firms, and clinicians met at  APA headquarters March 8 to discuss the shrinking investment in new drug  development for psychiatric disorders. The &ldquo;Pipeline Summit&rdquo; was organized and  supported entirely by the American Psychiatric Foundation (APF) after  APF was asked to convene the event by the leadership of the National  Institute of Mental Health (NIMH) and National Institute on Drug Abuse  (NIDA). They are concerned that psychiatry is facing a prolonged drought  of no new drugs for years to come. One by one, major pharmaceutical  companies have slashed or abandoned neuropsychiatric research programs.<\/p>\n<p>         There are huge unmet clinical needs in  mental disorders and addiction,&rdquo; said Jeffrey Lieberman, M.D., incoming  president-elect of APA and chair of psychiatry at Columbia University,  who moderated the morning session. &ldquo;There should be tremendous interest  in this area, but there is not.&rdquo; Psychiatric research and development programs have gained a high-cost, high-risk, and no-return  reputation in industry after dozens of failed programs, agreed senior  managers from several major companies at the summit&#8230;.<\/p>\n<p>       One of APF and APA&rsquo;s roles, Schatzberg said, is to continue to fight the stigma against psychiatry and psychiatric drugs. In addition to facilitating more collaboration between the government and the private sector, he proposed that APF and APA work with other stakeholders to create incentives for industry to reinvest in psychiatry. Philip Skolnick, D.Sc., Ph.D., of NIDA raised the issue of whether extending market exclusivity for compounds that are first in class and\/or first in indication as is done abroad could promote investment.  Thomas Laughren, M.D., director of the Division of Psychiatric Products at the FDA, suggested that APA could help the agency by organizing public discussions and publishing consensus on clinical endpoints, biomarkers, and standardized clinical definitions such as response and partial response.  In addition, APA will continue to advocate for more favorable reimbursement conditions for psychiatric services and new medical devices for treating mental illness, said Schatzberg.  &ldquo;APA has a role in shaping what future psychiatric practice looks like,&rdquo; Schatzberg stated. &ldquo;More needs to be done now if we are to have new treatments in the next decade for patients with psychiatric disorders&rdquo;&#8230;<\/sup><\/div>\n<\/blockquote>\n<div align=\"justify\">We all know what happened to <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8890670\" target=\"_blank\"><u><strong><font color=\"#200020\">Redefining the role of psychiatry in medicine<\/font><\/strong><\/u><\/a>. Rather than demonstrating the kind of expertise that engenders the respect of our peers in mental health and medicine, organized and academic psychiatry became an interest group itself, working for the pharmaceutical industry. They joined them by signing on as authors to their studies, giving talks on their products, advising their ad campaigns, accepting their grants, and even being paid personal salaries as &quot;speakers&quot; or &quot;advisors.&quot; The diagnostic system was already weighted in the direction of PHARMA, and that&#8217;s even being extended with the DSM-5. So we didn&#8217;t, as a profession, act very much like experts. <\/div>\n<p align=\"justify\">As a profession, the people at the top have acted like <em><strong><font color=\"#200020\">Mafioso<\/font><\/strong><\/em> [literally, honorary family members by virtue of loyalty] with PHARMA &#8211; <em>bought men<\/em>. And they treated our professional colleagues like <em><strong><font color=\"#200020\">Strangeri<\/font><\/strong><\/em> [others, not in the family]. Neither expertise nor mutual respect flowed from the <em><strong><font color=\"#200020\">Psychiatric Mafia<\/font><\/strong><\/em> that has dominated enough of the Key Opinion Leader set to turn the opinion of almost everyone sour &#8211; mine included. For Alan Schatzberg to say that we need &quot;<em><strong><font color=\"#200020\">to continue to fight the stigma against psychiatry and psychiatric drugs<\/font><\/strong><\/em>&quot; or &quot;<em><strong><font color=\"#200020\">[m]ore needs to be done now if we are to have new treatments in the next decade for patients with psychiatric disorders<\/font><\/strong><\/em>&quot; in a meeting at the APA headquarters simply confirms their dependence on this unholy alliance. So long as psychiatry continues to function as an interest group a la Alan Schatzberg [&quot;<em><strong><font color=\"#200020\">APA will continue to advocate for more favorable reimbursement  conditions for psychiatric services and new medical devices for treating  mental illness<\/font><\/strong><\/em>&quot;], the decline will continue as our ranks thin from the bottom up.<\/p>\n<div align=\"justify\">Could the process of <strong><font color=\"#200020\">redefining the role of psychiatry in medicine<\/font><\/strong> have gone more badly? I can&#8217;t imagine how&#8230;<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Redefining the role of psychiatry in medicine. by Lieberman JA and Rush AJ American Journal of Psychiatry. 1996 153:1388-1397. &#8230; The delivery of psychiatric services would be reorganized to emphasize what psychiatrists can do best. For example, the initial diagnostic evaluation would involve a reordering of services, with psychiatrists being the first to consult [after [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-22001","post","type-post","status-publish","format-standard","hentry","category-politics"],"_links":{"self":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22001","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/comments?post=22001"}],"version-history":[{"count":24,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22001\/revisions"}],"predecessor-version":[{"id":22064,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/posts\/22001\/revisions\/22064"}],"wp:attachment":[{"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/media?parent=22001"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/categories?post=22001"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1boringoldman.com\/index.php\/wp-json\/wp\/v2\/tags?post=22001"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}